At a glance
- Originator Novartis
- Class Piperidines; Pyridines; Small molecules
- Mechanism of Action PIM3 protein inhibitors; Proto oncogene proteins c pim 1 inhibitors; Proto-oncogene protein pim-2 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Haematological malignancies
Most Recent Events
- 03 Feb 2017 Chemical structure information added